BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile

  October 1, 2024

   · 

  4 min read
• Press Releases

  Nurix Therapeutics Announces Presentations at Discovery on Target Conference

  October 1, 2024

   · 

  5 min read
• Press Releases

  Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company

  October 1, 2024

   · 

  7 min read
• Press Releases

  Cartherics Raises Over $15 Million in Oversubscribed Private Financing Round to Advance Cell Therapy Programs

  October 1, 2024

   · 

  2 min read
• Press Releases

  Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2024

  October 1, 2024

   · 

  2 min read
• Press Releases

  Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2024

  October 1, 2024

   · 

  1 min read
• Press Releases

  Thrive Bioscience Welcomes Christiaan Erik Engstrom as Chief Operating Officer and VP of Corporate Development and Finance

  October 1, 2024

   · 

  2 min read
• Press Releases

  Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - September 30, 2024

  October 1, 2024

   · 

  1 min read
• Press Releases

  Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism

  October 1, 2024

   · 

  6 min read
• Press Releases

  Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia

  October 1, 2024

   · 

  3 min read